New Potent Antibacterial Oxazolidinone (MRX-I) with an Improved Class Safety Profile
Author:
Affiliation:
1. MicuRx Pharmaceuticals Inc., Hayward, California 94545, United States
Publisher
American Chemical Society (ACS)
Subject
Drug Discovery,Molecular Medicine
Link
https://pubs.acs.org/doi/pdf/10.1021/jm401931e
Reference53 articles.
1. A FATAL CASE OF APLASTIC ANEMIA FOLLOWING CHLORAMPHENICOL (CHLOROMYCETIN) THERAPY
2. The FDA and the Case of Ketek
3. Lessons from the withdrawal of rofecoxib: ***
4. FDA’s Sentinel Initiative;U.S. Food and Drug Administration:Silver Spring, MD;http://www.fda.gov/Safety/FDAsSentinelinitiative/ucm2007250.htm.
Cited by 115 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Tricyclic Benzo[1,3]oxazinyloxazolidinones as Potent Antibacterial Agents against Drug-Resistant Pathogens;Journal of Medicinal Chemistry;2024-09-05
2. Sepsis and pneumonia caused by Enterococcus faecium following liver transplantation treated with contezolid as the first-line therapy;Journal of Global Antimicrobial Resistance;2024-09
3. Contezolid for the Treatment of Drug-Resistant Tuberculosis in China: A Clinical Case Series;Infection and Drug Resistance;2024-08
4. Transition-Metal-Free Approach for the Synthesis of N-Arylated Piperidones and their Ketals from Ketene Dithioacetals;Synlett;2024-07-22
5. Novel biaryloxazolidinone derivatives with broad-spectrum antibacterial activity, favorable drug-like profiles and in vivo efficacy against linezolid-resistant Staphylococcus aureus;European Journal of Medicinal Chemistry;2024-07
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3